BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 33216979)

  • 21. Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid Tissue of the Salivary Glands: A Multicenter, International Experience of 248 Patients (IELSG 41).
    Jackson AE; Mian M; Kalpadakis C; Pangalis GA; Stathis A; Porro E; Conconi A; Cortelazzo S; Gaidano G; Lopez Guillermo A; Johnson PW; Martelli M; Martinelli G; Thieblemont C; McPhail ED; Copie-Bergman C; Pileri SA; Jack A; Campo E; Mazzucchelli L; Ristow K; Habermann TM; Cavalli F; Nowakowski GS; Zucca E
    Oncologist; 2015 Oct; 20(10):1149-53. PubMed ID: 26268740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Short survival and frequent transformation in extranodal marginal zone lymphoma with multiple mucosal sites presentation.
    Alderuccio JP; Zhao W; Desai A; Ramdial J; Gallastegui N; Kimble E; de la Fuente MI; Husnain M; Rosenblatt JD; Alencar AJ; Schatz JH; Moskowitz CH; Chapman JR; Vega F; Reis IM; Lossos IS
    Am J Hematol; 2019 May; 94(5):585-596. PubMed ID: 30784098
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic role of baseline
    Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
    Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.
    Melchardt T; Troppan K; Weiss L; Hufnagl C; Neureiter D; Tränkenschuh W; Hopfinger G; Magnes T; Deutsch A; Neumeister P; Hackl H; Greil R; Pichler M; Egle A
    Br J Haematol; 2015 Jan; 168(2):239-45. PubMed ID: 25236324
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the clinical characteristics and prognostic factors of gastrointestinal mucosa-associated lymphoid tissue (MALT) lymphoma.
    Xu X; Wang Z; Yu Y; Wang Y; Zhang L; Sun B; Da W; Zhang Y
    J Gastroenterol Hepatol; 2014 Sep; 29(9):1678-84. PubMed ID: 24730769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of different staging systems and prognostic analysis of 110 primary gastrointestinal diffuse large B cell lymphoma].
    Mao L; Wang X; Wang CY; Xia B; Ning QY; Yang HL; Yu Y; Zhang YZ
    Zhonghua Yi Xue Za Zhi; 2019 Jun; 99(24):1853-1858. PubMed ID: 31269579
    [No Abstract]   [Full Text] [Related]  

  • 27. Prognostic significance of serum β2-microglobulin levels in patients with peripheral T-cell lymphoma not otherwise specified.
    Kim HD; Cho H; Sohn BS; Park CS; Huh J; Ryu JS; Lee SW; Yoon SE; Kim SJ; Ko YH; Kim WS; Suh C
    Leuk Lymphoma; 2022 Jan; 63(1):124-130. PubMed ID: 34702115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beta2-microglobulin is a valuable marker and identifies a poor-prognosis subgroup among intermediate-risk patients with diffuse large B cell lymphoma.
    Chen NC; Chang H; Kao HW; Ou CW; Kuo MC; Wang PN; Lin TL; Wu JH; Hung YS; Su YJ; Ong YC; Shih HJ
    Clin Exp Med; 2023 Nov; 23(7):3759-3766. PubMed ID: 37086332
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical characteristics, diagnosis, treatment, and prognostic factors of pulmonary mucosa-associated lymphoid tissue-derived lymphoma.
    Wang L; Ye G; Liu Z; Shi L; Zhan C; Gu J; Luo R; Lin Z; Ge D; Wang Q
    Cancer Med; 2019 Dec; 8(18):7660-7668. PubMed ID: 31691549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Validation of the NCCN-IPI for diffuse large B-cell lymphoma (DLBCL): the addition of β
    Montalbán C; Díaz-López A; Dlouhy I; Rovira J; Lopez-Guillermo A; Alonso S; Martín A; Sancho JM; García O; Sánchez JM; Rodríguez M; Novelli S; Salar A; Gutiérrez A; Rodríguez-Salazar MJ; Bastos M; Domínguez JF; Fernández R; Gonzalez de Villambrosia S; Queizan JA; Córdoba R; de Oña R; López-Hernandez A; Freue JM; Garrote H; López L; Martin-Moreno AM; Rodriguez J; Abraira V; García JF;
    Br J Haematol; 2017 Mar; 176(6):918-928. PubMed ID: 28106247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of serum beta-2 microglobulin in patients with non-Hodgkin lymphoma.
    Wu L; Wang T; Gui W; Lin H; Xie K; Wang H; Gao T; Zhang X; Liu L; Han T; Tian Y; Hou L
    Oncology; 2014; 87(1):40-7. PubMed ID: 24969158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Non-gastric advanced mucosa-associated lymphoid tissue (MALT) lymphoma has worse prognosis than gastric MALT lymphoma even when treated with rituximab-containing chemotherapy.
    Ueda K; Terui Y; Yokoyama M; Sakajiri S; Nishimura N; Tsuyama N; Takeuchi K; Hatake K
    Leuk Lymphoma; 2013 Sep; 54(9):1928-33. PubMed ID: 23216271
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical characteristics and prognostic analysis of 90 patients with primary gastro-intestinal marginal zone lymphoma].
    Zhao X; Wang L; Zhang S; Wang S; Sun Y; Zhao W
    Zhonghua Xue Ye Xue Za Zhi; 2015 Jan; 36(1):24-8. PubMed ID: 25641141
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed.
    Thieblemont C; Berger F; Dumontet C; Moullet I; Bouafia F; Felman P; Salles G; Coiffier B
    Blood; 2000 Feb; 95(3):802-6. PubMed ID: 10648389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A New Prognostic Index for Extranodal Natural Killer/T-Cell Lymphoma:Incorporation of Serum β-2 Microglobulin to PINK.
    Kang S; Cho H; Kim S; Lee K; Kang EH; Park JS; Lee YS; Park CS; Go H; Huh J; Ryu JS; Lee SW; Kim SJ; Kim WS; Yoon SE; Ko YH; Suh C
    Cancer Res Treat; 2023 Jan; 55(1):314-324. PubMed ID: 35381163
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinicopathological features of histological transformation from extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue to diffuse large B-cell lymphoma: an analysis of 467 patients.
    Maeshima AM; Taniguchi H; Toyoda K; Yamauchi N; Makita S; Fukuhara S; Munakata W; Maruyama D; Kobayashi Y; Tobinai K
    Br J Haematol; 2016 Sep; 174(6):923-31. PubMed ID: 27460179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum beta2-microglobin is a predictor of prognosis in patients with upper aerodigestive tract NK/T-cell lymphoma.
    Li ZM; Zhu YJ; Sun J; Xia Y; Huang JJ; Zou BY; Lin TY; Huang HQ; Jiang WQ
    Ann Hematol; 2012 Aug; 91(8):1265-70. PubMed ID: 22373550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum IL-6, IL-8, IL-10 and beta2-microglobulin in association with International Prognostic Index in diffuse large B cell lymphoma.
    Duletić-Nacinović A; Stifter S; Marijić B; Lucin K; Valković T; Petranović D; Jonjić N
    Tumori; 2008; 94(4):511-7. PubMed ID: 18822687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Trends of Incidence and Survival Rates of Mucosa-associated Lymphoid Tissue Lymphoma in the Korean Population: Analysis of the Korea Central Cancer Registry Database.
    Jeong SH; Hyun SY; Choi JS; Kim HM
    J Korean Med Sci; 2020 Sep; 35(36):e294. PubMed ID: 32924338
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New prognosis score including absolute lymphocyte/monocyte ratio, red blood cell distribution width and beta-2 microglobulin in patients with diffuse large B-cell lymphoma treated with R-CHOP: Spanish Lymphoma Group Experience (GELTAMO).
    Bento L; Díaz-López A; Barranco G; Martín-Moreno AM; Baile M; Martín A; Sancho JM; García O; Rodríguez M; Sánchez-Pina JM; Novelli S; Salar A; Bastos M; Rodríguez-Salazar MJ; González de Villambrosia S; Córdoba R; García-Recio M; Martínez-Serra J; Del Campo R; Luzardo H; García D; Hong A; Abrisqueta P; Sastre-Serra J; Roca P; Rodríguez J; Gutiérrez A;
    Br J Haematol; 2020 Mar; 188(6):888-897. PubMed ID: 31782146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.